Yes, it can
Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
The dual mechanism produces complementary and additive weight loss effects
Link Maczurek, A., Hager, K., Kenklies, M., et al
Approximately 20.9% of patients on the 12 mg dose reported dysesthesia, a condition involving skin sensitivity, tingling, or tenderness to touch
Shipping : Free Shipping Estimated Delivery : 3-5 Business Days